Geneos Wealth Management’s HSBC HSBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $348K | Hold |
4,222
| – | – | 0.01% | 798 |
|
|
2025
Q4 | $332K | Hold |
4,222
| – | – | 0.01% | 777 |
|
|
2025
Q3 | $300K | Sell |
4,222
-2,529
| -37% | -$164K | 0.01% | 784 |
|
|
2025
Q2 | $410K | Sell |
6,751
-7,460
| -52% | -$425K | 0.01% | 771 |
|
|
2025
Q1 | $816K | Buy |
14,211
+9,003
| +173% | +$492K | 0.01% | 736 |
|
|
2024
Q4 | $258K | Sell |
5,208
-358
| -6% | -$16.6K | 0.01% | 760 |
|
|
2024
Q3 | $252K | Buy |
5,566
+517
| +10% | +$22.4K | 0.01% | 712 |
|
|
2024
Q2 | $220K | Sell |
5,049
-530
| -9% | -$22.8K | 0.01% | 684 |
|
|
2024
Q1 | $220K | Hold |
5,579
| – | – | 0.01% | 679 |
|
|
2023
Q4 | $226K | Sell |
5,579
-300
| -5% | -$11.6K | 0.01% | 653 |
|
|
2023
Q3 | $232K | Hold |
5,879
| – | – | 0.01% | 646 |
|
|
2023
Q2 | $233K | Buy |
5,879
+300
| +5% | +$11.2K | 0.01% | 648 |
|
|
2023
Q1 | $190K | Sell |
5,579
-300
| -5% | -$10.8K | 0.01% | 663 |
|
|
2022
Q4 | $183K | Sell |
5,879
-100
| -2% | -$2.84K | 0.01% | 648 |
|
|
2022
Q3 | $155K | Sell |
5,979
-438
| -7% | -$13.6K | 0.01% | 674 |
|
|
2022
Q2 | $209K | Sell |
6,417
-278
| -4% | -$9.02K | 0.01% | 731 |
|
|
2022
Q1 | $229K | Buy |
6,695
+4
| +0.1% | +$138 | 0.01% | 751 |
|
|
2021
Q4 | $201K | Hold |
6,691
| – | – | 0.01% | 861 |
|
|
2021
Q3 | $176K | Buy |
6,691
+1
| +0% | +$27 | 0.01% | 915 |
|
|
2021
Q2 | $192K | Sell |
6,690
-568
| -8% | -$17.3K | 0.01% | 861 |
|
|
2021
Q1 | $226K | Buy |
7,258
+1
| +0% | +$29 | 0.01% | 917 |
|
|
2020
Q4 | $211K | Sell |
7,257
-275
| -4% | -$6.53K | 0.01% | 806 |
|
|
2020
Q3 | $136K | Sell |
7,532
-800
| -10% | -$17.5K | 0.01% | 817 |
|
|
2020
Q2 | $194K | Sell |
8,332
-5,136
| -38% | -$128K | 0.01% | 683 |
|
|
2020
Q1 | $388K | Sell |
13,468
-8
| -0.1% | -$278 | 0.03% | 425 |
|
|
2019
Q4 | $525K | Buy |
13,476
+3,124
| +30% | +$118K | 0.03% | 425 |
|
|
2019
Q3 | $394K | Sell |
10,352
-526
| -5% | -$20.4K | 0.02% | 462 |
|
|
2019
Q2 | $454K | Sell |
10,878
-128
| -1% | -$5.36K | 0.03% | 428 |
|
|
2019
Q1 | $441K | Sell |
11,006
-2,443
| -18% | -$98.4K | 0.03% | 429 |
|
|
2018
Q4 | $532K | Buy |
13,449
+833
| +7% | +$33.4K | 0.04% | 356 |
|
|
2018
Q3 | $528K | Buy |
12,616
+7,773
| +160% | +$337K | 0.04% | 373 |
|
|
2018
Q2 | $215K | Buy |
4,843
+2,990
| +161% | +$137K | 0.02% | 552 |
|
|
2018
Q1 | $82K | Buy |
1,853
+482
| +35% | +$22.9K | 0.01% | 819 |
|
|
2017
Q4 | $64K | Buy |
1,371
+154
| +13% | +$6.96K | 0.01% | 900 |
|
|
2017
Q3 | $54K | Buy |
1,217
+11
| +0.9% | +$487 | 0.01% | 911 |
|
|
2017
Q2 | $51K | Buy |
1,206
+2
| +0.2% | +$78 | 0.01% | 911 |
|
|
2017
Q1 | $44K | Sell |
1,204
-380
| -24% | -$14.3K | ﹤0.01% | 937 |
|
|
2016
Q4 | $57K | Buy |
1,584
+28
| +2% | +$993 | 0.01% | 791 |
|
|
2016
Q3 | $52K | Sell |
1,556
-6
| -0.4% | -$188 | 0.01% | 798 |
|
|
2016
Q2 | $43K | Buy |
1,562
+942
| +152% | +$26.6K | 0.01% | 858 |
|
|
2016
Q1 | $17K | Buy |
+620
| New | +$18.3K | ﹤0.01% | 1139 |
|
Other funds holding HSBC
Geneos Wealth Management's HSBC Position: Q1 2026 in Review
Geneos Wealth Management held its HSBC (HSBC) position steady in Q1 2026 at 4,222 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #798.
Geneos Wealth Management first reported a position in HSBC in Q1 2016 and has held it in 41 quarters since. The position peaked at $816K in Q1 2025. 639 funds tracked by Wall St. Rank hold HSBC as of Q1 2026.
- Geneos Wealth Management held 4,222 shares of HSBC worth $348K as of Q1 2026.
- Geneos Wealth Management left its HSBC share count unchanged in Q1 2026.
- HSBC made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #798 holding.
- Geneos Wealth Management first reported a position in HSBC in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's HSBC position peaked at $816K in Q1 2025.
- 639 funds tracked by Wall St. Rank held HSBC as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.